<?xml version="1.0" encoding="UTF-8"?>
<p id="Par7">Anyway, it is well recognized that SARS-COV-2 infection alters coagulation pathway. Zhou et al. demonstrated that non-survivor COVID-19 patients show significant higher levels of plasma D-dimer, activated partial thromboplastin times, and prothrombin times compared with survivors [
 <xref ref-type="bibr" rid="CR6">6</xref>].
</p>
